JENBURKT PHARMACEUTICALS LTD.

Scale -

Revenue is 169 Rs Cr; Continuous Growth over 3 years
Ebitda is 54.04 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 14 %
PAT is 34.74 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 12 %
PBT is 6.77 Rs Cr; in Top Quartile; 5 Year CAGR is 12 %
Quarterly Profit is 5.89 Rs Cr; in Top Quartile

Profitability -

PBDIT Margin is 32.02 %; Continuous Growth over 3 years; in Top Quartile
PAT Margin is 20.58 %; in Top Quartile
Quarterly Ebitda Margin is 17 %; in Top Quartile
Quarterly Profit margin is 17 %; in Top Quartile

Return -

ROCE is 25.1 %; Continuous Growth over 3 years; in Top Quartile
ROA is 15.36 %; in Top Quartile
ROE is 17.62 %; in Top Quartile

Asset Turnover is 80 %; Continuous Decline over 3 years

Efficiency -

Current Ratio is 4.11; Annual Growth is 37 %; in Top Quartile
Quick Ratio is 3.52; Annual Growth is 39 %; in Top Quartile
Inventory Turnover Ratio is 14.99; in Top Quartile; 5 Year CAGR is 83 %
Operating cash flow is 26.52 Rs Cr; in Top Quartile; 5 Year CAGR is 30 %

Solvancy -

Debt/Equity is 0; Annual Decline is -100 %; in Bottom Quartile
Total Debt is 0 Rs Cr; Annual Decline is -100 %; in Bottom Quartile

Contingent Liabilities is 17.2 Rs Cr; in Top Quartile

Quality -

Change in Inventories/Total Expenses is -4 %; Annual Decline is -3499 %; in Bottom Quartile
Exceptional Items/PBT is -8 %; in Bottom Quartile
Operating cashflow/PAT is 76 %; 5 Year CAGR is 16 %

Other Expenses/Total Expenses is 32 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: